Previous Close | 223.37 |
1-Year Change | 57.51% |
6-Months Change | 34.84% |
3-Months Change | 7.37% |
Moving Avg (50d) | 196.44 |
Moving Avg (200d) | 184.2 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 302.2B |
Beta (3-Years) | 1.18 |
Revenue Growth (ttm) | 76.38% |
Net Profit Margin (ttm) | -43.52% |
Return On Assets (ttm) | -17.37% |
EPS (ttm) | -0.72 |
PE Ratio (ttm) | -310.24 |
Dividend Yield | % |
Asset Description: | BeiGene, Ltd. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-12-24 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
218.903 | 212.201 | 207.734 | 201.033 | 189.864 | 178.696 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.